-
1
-
-
84894740205
-
-
International Diabetes Federation, IDF Diabetes Atlas, 6th edn
-
International Diabetes Federation (2013) IDF Diabetes Atlas, 6th edn. Brussels, Belgium: International Diabetes Federation, http://www.idf.org/diabetesatlas
-
(2013)
Brussels, Belgium: International Diabetes Federation
-
-
-
2
-
-
33645924034
-
Prevalence of obesity in type 2 diabetes in secondary care: Association with cardiovascular risk factors
-
Daousi C, Casson IF, Gill GV, MacFarlane IA, Wilding JPH, Pinkney JH (2006) Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors. Postgrad Med J 82: 280-284
-
(2006)
Postgrad Med J
, vol.82
, pp. 280-284
-
-
Daousi, C.1
Casson, I.F.2
Gill, G.V.3
Macfarlane, I.A.4
Wilding, J.P.H.5
Pinkney, J.H.6
-
3
-
-
0032511583
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
-
UK Prospective Diabetes Study (UKPDS) Group
-
UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853
-
(1998)
Lancet
, vol.352
, pp. 837-853
-
-
-
4
-
-
33845405222
-
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
-
Kahn SE, Haffner SM, Heise MA et al (2006) Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 355: 2427-2443
-
(2006)
N Engl J Med
, vol.355
, pp. 2427-2443
-
-
Kahn, S.E.1
Haffner, S.M.2
Heise, M.A.3
-
5
-
-
79958838741
-
Impact of weight gain on outcomes in type 2 diabetes
-
Ross SA, Dzida G, Vora J, Khunti K, Kaiser M, Ligthelm RJ (2011) Impact of weight gain on outcomes in type 2 diabetes. Curr Med Res Opin 27: 1431-1438
-
(2011)
Curr Med Res Opin
, vol.27
, pp. 1431-1438
-
-
Ross, S.A.1
Dzida, G.2
Vora, J.3
Khunti, K.4
Kaiser, M.5
Ligthelm, R.J.6
-
6
-
-
23644460332
-
Impact of improved glycemic control on quality of life in patients with diabetes
-
Jacobson AM (2004) Impact of improved glycemic control on quality of life in patients with diabetes. Endocr Pract 10: 502-508
-
(2004)
Endocr Pract
, vol.10
, pp. 502-508
-
-
Jacobson, A.M.1
-
8
-
-
27144438407
-
-
World Health Organization. Accessed 15 Aug. 2013
-
World Health Organization. Diabetes programme. http://www.who.int/diabetes/en/. Accessed 15 Aug 2013
-
Diabetes Programme
-
-
-
9
-
-
0034844049
-
Mortality and causes of death in the WHO multinational study of vascular disease in diabetes
-
Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H (2001) Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia 44(Suppl 2): S14-S21
-
(2001)
Diabetologia
, vol.44
, pp. S14-S21
-
-
Morrish, N.J.1
Wang, S.L.2
Stevens, L.K.3
Fuller, J.H.4
Keen, H.5
-
10
-
-
79960087040
-
-
World Health Organization. Accessed 15 Aug 2013
-
World Health Organization (2011). Global status report on noncommunicable diseases 2010. http://www.who.int/nmh/publications/ncd-report2010/en/. Accessed 15 Aug 2013
-
(2011)
Global Status Report on Noncommunicable Diseases 2010
-
-
-
11
-
-
24144472565
-
The burden of mortality attributable to diabetes: Realistic estimates for the year 2000
-
Roglic G, Unwin N, Bennett PH, Mathers C, Tuomilehto J, Nag S, Connolly V, King H (2005) The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 28: 2130-2135
-
(2005)
Diabetes Care
, vol.28
, pp. 2130-2135
-
-
Roglic, G.1
Unwin, N.2
Bennett, P.H.3
Mathers, C.4
Tuomilehto, J.5
Nag, S.6
Connolly, V.7
King, H.8
-
13
-
-
84875769415
-
Evolving therapeutic options for type 2 diabetes mellitus: An overview
-
Guthrie RM (2012) Evolving therapeutic options for type 2 diabetes mellitus: an overview. Postgrad Med 124: 82-89
-
(2012)
Postgrad Med
, vol.124
, pp. 82-89
-
-
Guthrie, R.M.1
-
15
-
-
65949103197
-
Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
-
Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B (2009) Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 32: 193-203
-
(2009)
Diabetes Care
, vol.32
, pp. 193-203
-
-
Nathan, D.M.1
Buse, J.B.2
Davidson, M.B.3
Ferrannini, E.4
Holman, R.R.5
Sherwin, R.6
Zinman, B.7
-
16
-
-
0014155217
-
Purification and characterization of an aminopeptidase hydrolyzing glycyl-proline-naphthylamide
-
Hopsu-Havu VK, Sarimo SR (1967) Purification and characterization of an aminopeptidase hydrolyzing glycyl-proline-naphthylamide. Hoppe Seylers Z Physiol Chem 348: 1540-1550
-
(1967)
Hoppe Seylers Z Physiol Chem
, vol.348
, pp. 1540-1550
-
-
Hopsu-Havu, V.K.1
Sarimo, S.R.2
-
18
-
-
84893917196
-
Food protein hydrolysates as a source of dipeptidyl peptidase IV inhibitory peptides for the management of type 2 diabetes
-
Power O, Nongonierma AB, Jakeman P, Fitzgerald RJ (2013) Food protein hydrolysates as a source of dipeptidyl peptidase IV inhibitory peptides for the management of type 2 diabetes. Proc Nutr Soc 73: 34-46
-
(2013)
Proc Nutr Soc
, vol.73
, pp. 34-46
-
-
Power, O.1
Nongonierma, A.B.2
Jakeman, P.3
Fitzgerald, R.J.4
-
19
-
-
80054933500
-
Recent patents of dipeptidyl peptidase IV inhibitors
-
Mendieta L, Tarrago T, Giralt E (2011) Recent patents of dipeptidyl peptidase IV inhibitors. Expert Opin Ther Pat 21: 1693-1741
-
(2011)
Expert Opin Ther Pat
, vol.21
, pp. 1693-1741
-
-
Mendieta, L.1
Tarrago, T.2
Giralt, E.3
-
20
-
-
17144404555
-
Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders
-
Gorrell MD (2005) Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders. Clin Sci (Lond) 108: 277-292
-
(2005)
Clin Sci (Lond)
, vol.108
, pp. 277-292
-
-
Gorrell, M.D.1
-
21
-
-
84897390441
-
Dipeptidyl peptidase IV and its inhibitors therapeutics for type 2 diabetes and what else?
-
Juillerat-Jeanneret L (2014) Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else? J Med Chem 57: 2197-2212
-
(2014)
J Med Chem
, vol.57
, pp. 2197-2212
-
-
Juillerat-Jeanneret, L.1
-
22
-
-
0033619675
-
Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides
-
Mentlein R (1999) Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides. Regul Pept 85: 9-24
-
(1999)
Regul Pept
, vol.85
, pp. 9-24
-
-
Mentlein, R.1
-
23
-
-
84877061867
-
A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site
-
Nabeno M, Akahoshi F, Kishida H, Miyaguchi I, Tanaka Y, Ishii S, Kadowaki T (2013) A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site. Biochem Biophys Res Commun 434: 191-196
-
(2013)
Biochem Biophys Res Commun
, vol.434
, pp. 191-196
-
-
Nabeno, M.1
Akahoshi, F.2
Kishida, H.3
Miyaguchi, I.4
Tanaka, Y.5
Ishii, S.6
Kadowaki, T.7
-
24
-
-
0042131827
-
Structural basis of proline- specific exopeptidase activity as observed in human dipeptidyl peptidase-IV
-
Thoma R, Löffler B, Stihle M, Huber W, Ruf A, Hennig M (2003) Structural basis of proline- specific exopeptidase activity as observed in human dipeptidyl peptidase-IV. Structure 11: 947-959
-
(2003)
Structure
, vol.11
, pp. 947-959
-
-
Thoma, R.1
Löffler, B.2
Stihle, M.3
Huber, W.4
Ruf, A.5
Hennig, M.6
-
25
-
-
85192413206
-
Inhibitors of dipeptidyl peptidase
-
Doherty AM, Bock MG, Desai MC, Overington J, Plattner JJ, Stamford A, Wustrow D, Young H, Gwaltney SL, Stafford JA (2005) Inhibitors of dipeptidyl peptidase. Annu Rep Med Chem 40: 149-165
-
(2005)
Annu Rep Med Chem
, vol.40
, pp. 149-165
-
-
Doherty, A.M.1
Bock, M.G.2
Desai, M.C.3
Overington, J.4
Plattner, J.J.5
Stamford, A.6
Wustrow, D.7
Young, H.8
Gwaltney, S.L.9
Stafford, J.A.10
-
26
-
-
10644296948
-
One site mutation disrupts dimer formation in human DPP-IV proteins
-
Chien C-H, Huang L-H, Chou C-Y, Chen Y-S, Han Y-S, Chang G-G, Liang P-H, Chen X (2004) One site mutation disrupts dimer formation in human DPP-IV proteins. J Biol Chem 279: 52338-52345
-
(2004)
J Biol Chem
, vol.279
, pp. 52338-52345
-
-
Chien, C.-H.1
Huang, L.-H.2
Chou, C.-Y.3
Chen, Y.-S.4
Han, Y.-S.5
Chang, G.-G.6
Liang, P.-H.7
Chen, X.8
-
27
-
-
0037966007
-
The crystal structure of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic mechanism
-
Engel M, Hoffmann T, Wagner L, Wermann M, Heiser U, Kiefersauer R, Huber R, Bode W, Demuth H-U, Brandstetter H (2003) The crystal structure of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic mechanism. Proc Natl Acad Sci U S A 100: 5063-5068
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 5063-5068
-
-
Engel, M.1
Hoffmann, T.2
Wagner, L.3
Wermann, M.4
Heiser, U.5
Kiefersauer, R.6
Huber, R.7
Bode, W.8
Demuth, H.-U.9
Brandstetter, H.10
-
28
-
-
0031870418
-
Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide
-
Pederson RA, White HA, Schlenzig D, Pauly RP, McIntosh CH, Demuth HU (1998) Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide. Diabetes 47: 1253-1258
-
(1998)
Diabetes
, vol.47
, pp. 1253-1258
-
-
Pederson, R.A.1
White, H.A.2
Schlenzig, D.3
Pauly, R.P.4
McIntosh, C.H.5
Demuth, H.U.6
-
29
-
-
0036724721
-
Long-term treatment with dipeptidyl peptidase IV inhibitor improves hepatic and peripheral insulin sensitivity in the VDF Zucker rat: A euglycemic-hyperinsulinemic clamp study
-
Pospisilik JA, Stafford SG, Demuth H-U, McIntosh CHS, Pederson RA (2002) Long-term treatment with dipeptidyl peptidase IV inhibitor improves hepatic and peripheral insulin sensitivity in the VDF Zucker rat: a euglycemic-hyperinsulinemic clamp study. Diabetes 51: 2677-2683
-
(2002)
Diabetes
, vol.51
, pp. 2677-2683
-
-
Pospisilik, J.A.1
Stafford, S.G.2
Demuth, H.-U.3
McIntosh, C.H.S.4
Pederson, R.A.5
-
30
-
-
0037102412
-
Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model
-
Cheng JD, Dunbrack RL, Valianou M, Rogatko A, Alpaugh RK, Weiner LM (2002) Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model. Cancer Res 62: 4767-4772
-
(2002)
Cancer Res
, vol.62
, pp. 4767-4772
-
-
Cheng, J.D.1
Dunbrack, R.L.2
Valianou, M.3
Rogatko, A.4
Alpaugh, R.K.5
Weiner, L.M.6
-
31
-
-
0037093198
-
Prolonged survival and decreased invasive activity attributable to dipeptidyl peptidase IV overexpression in ovarian carcinoma
-
Kajiyama H, Kikkawa F, Suzuki T, Shibata K, Ino K, Mizutani S (2002) Prolonged survival and decreased invasive activity attributable to dipeptidyl peptidase IV overexpression in ovarian carcinoma. Cancer Res 62: 2753-2757
-
(2002)
Cancer Res
, vol.62
, pp. 2753-2757
-
-
Kajiyama, H.1
Kikkawa, F.2
Suzuki, T.3
Shibata, K.4
Ino, K.5
Mizutani, S.6
-
32
-
-
0034776255
-
In vitro and in vivo antitumor effect of the anti- CD26 monoclonal antibody 1F7 on human CD30+ anaplastic large cell T-cell lymphoma Karpas 299
-
Ho L, Aytac U, Stephens LC et al (2001) In vitro and in vivo antitumor effect of the anti- CD26 monoclonal antibody 1F7 on human CD30+ anaplastic large cell T-cell lymphoma Karpas 299. Clin Cancer Res 7: 2031-2040
-
(2001)
Clin Cancer Res
, vol.7
, pp. 2031-2040
-
-
Ho, L.1
Aytac, U.2
Stephens, L.C.3
-
33
-
-
84870205804
-
The impact of current and novel anti-diabetic therapies on cardiovascular risk
-
Ussher JR, Sutendra G, Jaswal JS (2012) The impact of current and novel anti-diabetic therapies on cardiovascular risk. Future Cardiol 8: 895-912
-
(2012)
Future Cardiol
, vol.8
, pp. 895-912
-
-
Ussher, J.R.1
Sutendra, G.2
Jaswal, J.S.3
-
34
-
-
84872424922
-
An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: Potential implications in cardiovascular disease
-
Zhong J, Rao X, Rajagopalan S (2013) An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: potential implications in cardiovascular disease. Atherosclerosis 226: 305-314
-
(2013)
Atherosclerosis
, vol.226
, pp. 305-314
-
-
Zhong, J.1
Rao, X.2
Rajagopalan, S.3
-
35
-
-
84865492997
-
Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus
-
Patil HR, Al Badarin FJ, Al Shami HA, Bhatti SK, Lavie CJ, Bell DSH, O'Keefe JH (2012) Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus. Am J Cardiol 110: 826-833
-
(2012)
Am J Cardiol
, vol.110
, pp. 826-833
-
-
Patil, H.R.1
Al Badarin, F.J.2
Al Shami, H.A.3
Bhatti, S.K.4
Lavie, C.J.5
Dsh, B.6
O'keefe, J.H.7
-
36
-
-
77953108350
-
A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetes
-
Frederich R, Alexander JH, Fiedorek FT, Donovan M, Berglind N, Harris S, Chen R, Wolf R, Mahaffey KW (2010) A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetes. Postgrad Med 122: 16-27
-
(2010)
Postgrad Med
, vol.122
, pp. 16-27
-
-
Frederich, R.1
Alexander, J.H.2
Fiedorek, F.T.3
Donovan, M.4
Berglind, N.5
Harris, S.6
Chen, R.7
Wolf, R.8
Mahaffey, K.W.9
-
37
-
-
84873099484
-
Cardiovascular effects of gliptins
-
Scheen AJ (2013) Cardiovascular effects of gliptins. Nat Rev Cardiol 10: 73-84
-
(2013)
Nat Rev Cardiol
, vol.10
, pp. 73-84
-
-
Scheen, A.J.1
-
38
-
-
84870049055
-
Cardiovascular protective properties of incretin-based therapies in type 2 diabetes
-
Simsek S, de Galan BE (2012) Cardiovascular protective properties of incretin-based therapies in type 2 diabetes. Curr Opin Lipidol 23: 540-547
-
(2012)
Curr Opin Lipidol
, vol.23
, pp. 540-547
-
-
Simsek, S.1
De Galan, B.E.2
-
39
-
-
84890570105
-
Dipeptidyl peptidase-4 inhibitors in cardioprotection: A promising therapeutic approach
-
Dai Y, Dai D, Mercanti F, Ding Z, Wang X, Mehta JL (2013) Dipeptidyl peptidase-4 inhibitors in cardioprotection: a promising therapeutic approach. Acta Diabetol 50: 827-835
-
(2013)
Acta Diabetol
, vol.50
, pp. 827-835
-
-
Dai, Y.1
Dai, D.2
Mercanti, F.3
Ding, Z.4
Wang, X.5
Mehta, J.L.6
-
40
-
-
84882282651
-
Cardiovascular effects of dipeptidyl peptidase-4 inhibitors: From risk factors to clinical outcomes
-
Scheen AJ (2013) Cardiovascular effects of dipeptidyl peptidase-4 inhibitors: from risk factors to clinical outcomes. Postgrad Med 125: 7-20
-
(2013)
Postgrad Med
, vol.125
, pp. 7-20
-
-
Scheen, A.J.1
-
41
-
-
84878134420
-
The effects of dipeptidyl peptidase-4 inhibitors on cardiovascular disease risks in type 2 diabetes mellitus
-
Yousefzadeh P, Wang X (2013) The effects of dipeptidyl peptidase-4 inhibitors on cardiovascular disease risks in type 2 diabetes mellitus. J Diabetes Res 2013: 459821
-
(2013)
J Diabetes Res
, vol.2013
, pp. 459821
-
-
Yousefzadeh, P.1
Wang, X.2
-
42
-
-
84879258494
-
Cardiovascular pleiotropic actions of DPP-4 inhibitors: A step at the cutting edge in understanding their additional therapeutic potentials
-
Balakumar P, Dhanaraj SA (2013) Cardiovascular pleiotropic actions of DPP-4 inhibitors: a step at the cutting edge in understanding their additional therapeutic potentials. Cell Signal 25: 1799-1803
-
(2013)
Cell Signal
, vol.25
, pp. 1799-1803
-
-
Balakumar, P.1
Dhanaraj, S.A.2
-
43
-
-
38449101374
-
Fibroblast activation protein and chronic liver disease
-
Wang XM, Yao T-W, Nadvi NA, Osborne B, McCaughan GW, Gorrell MD (2008) Fibroblast activation protein and chronic liver disease. Front Biosci 13: 3168-3180
-
(2008)
Front Biosci
, vol.13
, pp. 3168-3180
-
-
Wang, X.M.1
Yao, T.-W.2
Nadvi, N.A.3
Osborne, B.4
McCaughan, G.W.5
Gorrell, M.D.6
-
44
-
-
70549096922
-
Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition
-
Kirby M, Yu DMT, O'Connor S, Gorrell MD (2010) Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition. Clin Sci (Lond) 118: 31-41
-
(2010)
Clin Sci (Lond)
, vol.118
, pp. 31-41
-
-
Kirby, M.1
Yu, D.M.T.2
O'connor, S.3
Gorrell, M.D.4
-
45
-
-
25844459084
-
Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: Potential importance of selectivity over dipeptidyl peptidases 8 and 9
-
Lankas GR, Leiting B, Roy RS et al (2005) Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9. Diabetes 54: 2988-2994
-
(2005)
Diabetes
, vol.54
, pp. 2988-2994
-
-
Lankas, G.R.1
Leiting, B.2
Roy, R.S.3
-
46
-
-
84856023179
-
Physiology of incretins in health and disease
-
Deacon CF, Ahrén B (2011) Physiology of incretins in health and disease. Rev Diabet Stud 8: 293-306
-
(2011)
Rev Diabet Stud
, vol.8
, pp. 293-306
-
-
Deacon, C.F.1
Ahrén, B.2
-
47
-
-
84884806808
-
Incretin hormones and beta-cell mass expansion: What we know and what is missing?
-
Tortosa F, Dotta F (2013) Incretin hormones and beta-cell mass expansion: what we know and what is missing? Arch Physiol Biochem 119: 161-169
-
(2013)
Arch Physiol Biochem
, vol.119
, pp. 161-169
-
-
Tortosa, F.1
Dotta, F.2
-
48
-
-
84878753499
-
Incretin dysfunction in type 2 diabetes: Clinical impact and future perspectives
-
Ahrén B (2013) Incretin dysfunction in type 2 diabetes: clinical impact and future perspectives. Diabetes Metab 39: 195-201
-
(2013)
Diabetes Metab
, vol.39
, pp. 195-201
-
-
Ahrén, B.1
-
49
-
-
84884798819
-
Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity
-
Opinto G, Natalicchio A, Marchetti P (2013) Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity. Arch Physiol Biochem 119: 170-178
-
(2013)
Arch Physiol Biochem
, vol.119
, pp. 170-178
-
-
Opinto, G.1
Natalicchio, A.2
Marchetti, P.3
-
50
-
-
84884191059
-
Integrating incretin-based therapy into type 2 diabetes management
-
Brunton S (2013) Integrating incretin-based therapy into type 2 diabetes management. Vital Signs 62: S1-S8
-
(2013)
Vital Signs
, vol.62
, pp. S1-S8
-
-
Brunton, S.1
-
51
-
-
84876432038
-
Influence of diabetes surgery on gut hormones and incretins
-
Papamargaritis D, Miras AD, le Roux CW (2013) Influence of diabetes surgery on gut hormones and incretins. Nutr Hosp 28(Suppl 2): 95-103
-
(2013)
Nutr Hosp
, vol.28
, pp. 95-103
-
-
Papamargaritis, D.1
Miras, A.D.2
Le Roux, C.W.3
-
52
-
-
0037098963
-
Gastric inhibitory polypeptide: The neglected incretin revisited
-
Meier JJ, Nauck MA, Schmidt WE, Gallwitz B (2002) Gastric inhibitory polypeptide: the neglected incretin revisited. Regul Pept 107: 1-13
-
(2002)
Regul Pept
, vol.107
, pp. 1-13
-
-
Meier, J.J.1
Nauck, M.A.2
Schmidt, W.E.3
Gallwitz, B.4
-
53
-
-
33748660679
-
Inhibition of dipeptidylpeptidase IV activity as a therapy of type 2 diabetes
-
Green BD, Flatt PR, Bailey CJ (2006) Inhibition of dipeptidylpeptidase IV activity as a therapy of type 2 diabetes. Expert Opin Emerg Drugs 11: 525-539
-
(2006)
Expert Opin Emerg Drugs
, vol.11
, pp. 525-539
-
-
Green, B.D.1
Flatt, P.R.2
Bailey, C.J.3
-
54
-
-
68549099584
-
Differential islet and incretin hormone responses in morning versus afternoon after standardized meal in healthy men
-
Lindgren O, Mari A, Deacon CF, Carr RD, Winzell MS, Vikman J, Ahrén B (2009) Differential islet and incretin hormone responses in morning versus afternoon after standardized meal in healthy men. J Clin Endocrinol Metab 94: 2887-2892
-
(2009)
J Clin Endocrinol Metab
, vol.94
, pp. 2887-2892
-
-
Lindgren, O.1
Mari, A.2
Deacon, C.F.3
Carr, R.D.4
Winzell, M.S.5
Vikman, J.6
Ahrén, B.7
-
55
-
-
78649341328
-
Incretin hormone secretion over the day
-
Ahrén B, Carr RD, Deacon CF (2010) Incretin hormone secretion over the day. Vitam Horm 84: 203-220
-
(2010)
Vitam Horm
, vol.84
, pp. 203-220
-
-
Ahrén, B.1
Carr, R.D.2
Deacon, C.F.3
-
56
-
-
75749088373
-
Medicinal chemistry of incretin mimetics and DPP-4 inhibitors
-
Zettl H, Schubert-Zsilavecz M, Steinhilber D (2010) Medicinal chemistry of incretin mimetics and DPP-4 inhibitors. ChemMedChem 5: 179-185
-
(2010)
ChemMedChem
, vol.5
, pp. 179-185
-
-
Zettl, H.1
Schubert-Zsilavecz, M.2
Steinhilber, D.3
-
57
-
-
33846006173
-
The incretin system: Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
-
Drucker DJ, Nauck MA (2006) The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368: 1696-1705
-
(2006)
Lancet
, vol.368
, pp. 1696-1705
-
-
Drucker, D.J.1
Nauck, M.A.2
-
58
-
-
57649234120
-
The incretin system and its role in type 2 diabetes mellitus
-
Holst JJ, Vilsbøll T, Deacon CF (2009) The incretin system and its role in type 2 diabetes mellitus. Mol Cell Endocrinol 297: 127-136
-
(2009)
Mol Cell Endocrinol
, vol.297
, pp. 127-136
-
-
Holst, J.J.1
Vilsbøll, T.2
Deacon, C.F.3
-
59
-
-
14044264798
-
Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus
-
Holst JJ, Deacon CF (2004) Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus. Curr Opin Pharmacol 4: 589-596
-
(2004)
Curr Opin Pharmacol
, vol.4
, pp. 589-596
-
-
Holst, J.J.1
Deacon, C.F.2
-
60
-
-
34248223285
-
Biology of incretins: GLP-1 and GIP
-
Baggio LL, Drucker DJ (2007) Biology of incretins: GLP-1 and GIP. Gastroenterology 132: 2131-2157
-
(2007)
Gastroenterology
, vol.132
, pp. 2131-2157
-
-
Baggio, L.L.1
Drucker, D.J.2
-
61
-
-
0037234531
-
Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes
-
Drucker DJ (2003) Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes. Expert Opin Investig Drugs 12: 87-100
-
(2003)
Expert Opin Investig Drugs
, vol.12
, pp. 87-100
-
-
Drucker, D.J.1
-
62
-
-
58149467276
-
Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon- like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes
-
Højberg PV, Vilsbøll T, Rabøl R, Knop FK, Bache M, Krarup T, Holst JJ, Madsbad S (2009) Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon- like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes. Diabetologia 52: 199-207
-
(2009)
Diabetologia
, vol.52
, pp. 199-207
-
-
Højberg, P.V.1
Vilsbøll, T.2
Rabøl, R.3
Knop, F.K.4
Bache, M.5
Krarup, T.6
Holst, J.J.7
Madsbad, S.8
-
63
-
-
84859529805
-
Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects
-
Hansen KB, Vilsbøll T, Bagger JI, Holst JJ, Knop FK (2012) Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects. J Clin Endocrinol Metab 97: 1363-1370
-
(2012)
J Clin Endocrinol Metab
, vol.97
, pp. 1363-1370
-
-
Hansen, K.B.1
Vilsbøll, T.2
Bagger, J.I.3
Holst, J.J.4
Knop, F.K.5
-
65
-
-
84885950010
-
Gemigliptin, a novel dipeptidyl peptidase 4 inhibitor: First new anti-diabetic drug in the history of Korean pharmaceutical industry
-
Kim S-H, Lee S-H, Yim H-J (2013) Gemigliptin, a novel dipeptidyl peptidase 4 inhibitor: first new anti-diabetic drug in the history of Korean pharmaceutical industry. Arch Pharm Res 36: 1185-1188
-
(2013)
Arch Pharm Res
, vol.36
, pp. 1185-1188
-
-
Kim, S.-H.1
Lee, S.-H.2
Yim, H.-J.3
-
69
-
-
65949111736
-
Increased risk of acute pancreatitis and biliary disease observed in patients with type 2 diabetes: A retrospective cohort study
-
Noel RA, Braun DK, Patterson RE, Bloomgren GL (2009) Increased risk of acute pancreatitis and biliary disease observed in patients with type 2 diabetes: a retrospective cohort study. Diabetes Care 32: 834-838
-
(2009)
Diabetes Care
, vol.32
, pp. 834-838
-
-
Noel, R.A.1
Braun, D.K.2
Patterson, R.E.3
Bloomgren, G.L.4
-
70
-
-
77952692112
-
Sitagliptin: Review of preclinical and clinical data regarding incidence of pancreatitis
-
Engel SS, Williams-Herman DE, Golm GT, Clay RJ, Machotka S V, Kaufman KD, Goldstein BJ (2010) Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis. Int J Clin Pract 64: 984-990
-
(2010)
Int J Clin Pract
, vol.64
, pp. 984-990
-
-
Engel, S.S.1
Williams-Herman, D.E.2
Golm, G.T.3
Clay, R.J.4
Machotka, S.V.5
Kaufman, K.D.6
Goldstein, B.J.7
-
71
-
-
77951069227
-
Safety and tolerability of sitagliptin in clinical studies: A pooled analysis of data from 10,246 patients with type 2 diabetes
-
Williams-Herman D, Engel SS, Round E, Johnson J, Golm GT, Guo H, Musser BJ, Davies MJ, Kaufman KD, Goldstein BJ (2010) Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes. BMC Endocr Disord 10: 7
-
(2010)
BMC Endocr Disord
, vol.10
, pp. 7
-
-
Williams-Herman, D.1
Engel, S.S.2
Round, E.3
Johnson, J.4
Golm, G.T.5
Guo, H.6
Musser, B.J.7
Davies, M.J.8
Kaufman, K.D.9
Goldstein, B.J.10
-
72
-
-
84885384645
-
Safety and tolerability of sitagliptin in type 2 diabetes: Pooled analysis of 25 clinical studies
-
Engel SS, Round E, Golm GT, Kaufman KD, Goldstein BJ (2013) Safety and tolerability of sitagliptin in type 2 diabetes: pooled analysis of 25 clinical studies. Diabetes Ther 4: 119-145
-
(2013)
Diabetes Ther
, vol.4
, pp. 119-145
-
-
Engel, S.S.1
Round, E.2
Golm, G.T.3
Kaufman, K.D.4
Goldstein, B.J.5
-
73
-
-
84890564960
-
Dipeptidyl peptidase-4 inhibitors and pancreatitis risk: A meta-analysis of randomized clinical trials
-
Monami M, Dicembrini I, Mannucci E (2014) Dipeptidyl peptidase-4 inhibitors and pancreatitis risk: a meta-analysis of randomized clinical trials. Diabetes Obes Metab 16: 48-56
-
(2014)
Diabetes Obes Metab
, vol.16
, pp. 48-56
-
-
Monami, M.1
Dicembrini, I.2
Mannucci, E.3
-
74
-
-
84878616155
-
Gliptins (dipeptidyl peptidase-4 inhibitors) and risk of acute pancreatitis
-
Scheen A (2013) Gliptins (dipeptidyl peptidase-4 inhibitors) and risk of acute pancreatitis. Expert Opin Drug Saf 12: 545-557
-
(2013)
Expert Opin Drug Saf
, vol.12
, pp. 545-557
-
-
Scheen, A.1
-
75
-
-
84884538670
-
Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: Comparison, efficacy and safety
-
Deacon CF, Holst JJ (2013) Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety. Expert Opin Pharmacother 14: 2047-2058
-
(2013)
Expert Opin Pharmacother
, vol.14
, pp. 2047-2058
-
-
Deacon, C.F.1
Holst, J.J.2
-
76
-
-
84866285243
-
Anti-diabetic drugs and kidney disease-recommendations of the Swiss Society for Endocrinology and Diabetology
-
Zanchi A, Lehmann R, Philippe J (2012) Anti-diabetic drugs and kidney disease-recommendations of the Swiss Society for Endocrinology and Diabetology. Swiss Med Wkly 142: w13629
-
(2012)
Swiss Med Wkly
, vol.142
, pp. w13629
-
-
Zanchi, A.1
Lehmann, R.2
Philippe, J.3
-
77
-
-
84888876440
-
Clinical practice considerations and review of the literature for the use of DPP-4 inhibitors in patients with type 2 diabetes and chronic kidney disease
-
Ramirez G, Morrison AD, Bittle PA (2013) Clinical practice considerations and review of the literature for the use of DPP-4 inhibitors in patients with type 2 diabetes and chronic kidney disease. Endocr Pract 19: 1025-1034
-
(2013)
Endocr Pract
, vol.19
, pp. 1025-1034
-
-
Ramirez, G.1
Morrison, A.D.2
Bittle, P.A.3
-
78
-
-
33947705084
-
Molecular recognition of ligands in dipeptidyl peptidase IV
-
Kuhn B, Hennig M, Mattei P (2007) Molecular recognition of ligands in dipeptidyl peptidase IV. Curr Top Med Chem 7: 609-619
-
(2007)
Curr Top Med Chem
, vol.7
, pp. 609-619
-
-
Kuhn, B.1
Hennig, M.2
Mattei, P.3
-
79
-
-
29144522905
-
Rigidity and flexibility of dipeptidyl peptidase IV: Crystal structures of and docking experiments with DPIV
-
Engel M, Hoffmann T, Manhart S, Heiser U, Chambre S, Huber R, Demuth H-U, Bode W (2006) Rigidity and flexibility of dipeptidyl peptidase IV: crystal structures of and docking experiments with DPIV. J Mol Biol 355: 768-783
-
(2006)
J Mol Biol
, vol.355
, pp. 768-783
-
-
Engel, M.1
Hoffmann, T.2
Manhart, S.3
Heiser, U.4
Chambre, S.5
Huber, R.6
Demuth, H.-U.7
Bode, W.8
-
80
-
-
79955708969
-
Possible ligand release pathway of dipeptidyl peptidase IV investigated by molecular dynamics simulations
-
Li C, Shen J, Li W, Lu C (2011) Possible ligand release pathway of dipeptidyl peptidase IV investigated by molecular dynamics simulations. Proteins Struct Funct Bioinforma 79: 1800-1809
-
(2011)
Proteins Struct Funct Bioinforma
, vol.79
, pp. 1800-1809
-
-
Li, C.1
Shen, J.2
Li, W.3
Lu, C.4
-
81
-
-
84871911898
-
On the size of the active site in proteases. I. Papain. 1967
-
Schechter I, Berger A (2012) On the size of the active site in proteases. I. Papain. 1967. Biochem Biophys Res Commun 425: 497-502
-
(2012)
Biochem Biophys Res Commun
, vol.425
, pp. 497-502
-
-
Schechter, I.1
Berger, A.2
-
82
-
-
3843072211
-
Dipeptidyl peptidase IV inhibitors for the treatment of diabetes
-
Weber AE (2004) Dipeptidyl peptidase IV inhibitors for the treatment of diabetes. J Med Chem 47: 4135-4141
-
(2004)
J Med Chem
, vol.47
, pp. 4135-4141
-
-
Weber, A.E.1
-
83
-
-
41349100946
-
Structure-based design and synthesis of benzimidazole derivatives as dipeptidyl peptidase IV inhibitors
-
Wallace MB, Feng J, Zhang Z, Skene RJ, Shi L, Caster CL, Kassel DB, Xu R, Gwaltney SL (2008) Structure-based design and synthesis of benzimidazole derivatives as dipeptidyl peptidase IV inhibitors. Bioorg Med Chem Lett 18: 2362-2367
-
(2008)
Bioorg Med Chem Lett
, vol.18
, pp. 2362-2367
-
-
Wallace, M.B.1
Feng, J.2
Zhang, Z.3
Skene, R.J.4
Shi, L.5
Caster, C.L.6
Kassel, D.B.7
Xu, R.8
Gwaltney, S.L.9
-
84
-
-
84881177240
-
Computational studies on structurally diverse dipeptidyl peptidase IV inhibitors: An approach for new anti-diabetic drug development
-
Patel B, Ghate M (2013) Computational studies on structurally diverse dipeptidyl peptidase IV inhibitors: an approach for new anti-diabetic drug development. Med Chem Res 22: 4505-4521
-
(2013)
Med Chem Res
, vol.22
, pp. 4505-4521
-
-
Patel, B.1
Ghate, M.2
-
85
-
-
56049116069
-
Discovery of DPP IV inhibitors by pharmacophore modeling and QSAR analysis followed by in silico screening
-
Al-Masri IM, Mohammad MK, Taha MO (2008) Discovery of DPP IV inhibitors by pharmacophore modeling and QSAR analysis followed by in silico screening. ChemMedChem 3: 1763-1779
-
(2008)
ChemMedChem
, vol.3
, pp. 1763-1779
-
-
Al-Masri, I.M.1
Mohammad, M.K.2
Taha, M.O.3
-
86
-
-
1642534610
-
Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation
-
Aertgeerts K, Ye S, Tennant MG, Kraus ML, Rogers J, Sang B-C, Skene RJ, Webb DR, Prasad GS (2004) Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation. Protein Sci 13: 412-421
-
(2004)
Protein Sci
, vol.13
, pp. 412-421
-
-
Aertgeerts, K.1
Ye, S.2
Tennant, M.G.3
Kraus, M.L.4
Rogers, J.5
Sang, B.-C.6
Skene, R.J.7
Webb, D.R.8
Prasad, G.S.9
-
87
-
-
4544237622
-
Tyrosine 547 constitutes an essential part of the catalytic mechanism of dipeptidyl peptidase IV
-
Bjelke JR, Christensen J, Branner S, Wagtmann N, Olsen C, Kanstrup AB, Rasmussen HB (2004) Tyrosine 547 constitutes an essential part of the catalytic mechanism of dipeptidyl peptidase IV. J Biol Chem 279: 34691-34697
-
(2004)
J Biol Chem
, vol.279
, pp. 34691-34697
-
-
Bjelke, J.R.1
Christensen, J.2
Branner, S.3
Wagtmann, N.4
Olsen, C.5
Kanstrup, A.B.6
Rasmussen, H.B.7
-
88
-
-
84866353450
-
Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin- 2-ylcarbonyl]thiazolidine): A highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for t
-
Yoshida T, Akahoshi F, Sakashita H, et al (2012) Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin- 2-ylcarbonyl]thiazolidine): a highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for t. Bioorg Med Chem 20: 5705-5719
-
(2012)
Bioorg Med Chem
, vol.20
, pp. 5705-5719
-
-
Yoshida, T.1
Akahoshi, F.2
Sakashita, H.3
-
89
-
-
84864436192
-
Fused bicyclic heteroarylpiperazine-substituted L-prolylthiazolidines as highly potent DPP-4 inhibitors lacking the electrophilic nitrile group
-
Yoshida T, Akahoshi F, Sakashita H, Sonda S, Takeuchi M, Tanaka Y, Nabeno M, Kishida H, Miyaguchi I, Hayashi Y (2012) Fused bicyclic heteroarylpiperazine-substituted L-prolylthiazolidines as highly potent DPP-4 inhibitors lacking the electrophilic nitrile group. Bioorg Med Chem 20: 5033-5041
-
(2012)
Bioorg Med Chem
, vol.20
, pp. 5033-5041
-
-
Yoshida, T.1
Akahoshi, F.2
Sakashita, H.3
Sonda, S.4
Takeuchi, M.5
Tanaka, Y.6
Nabeno, M.7
Kishida, H.8
Miyaguchi, I.9
Hayashi, Y.10
-
90
-
-
67650002790
-
Aminopiperidine-fused imidazoles as dipeptidyl peptidase-IV inhibitors
-
Edmondson SD, Mastracchio A, Cox JM et al (2009) Aminopiperidine-fused imidazoles as dipeptidyl peptidase-IV inhibitors. Bioorg Med Chem Lett 19: 4097-4101
-
(2009)
Bioorg Med Chem Lett
, vol.19
, pp. 4097-4101
-
-
Edmondson, S.D.1
Mastracchio, A.2
Cox, J.M.3
-
91
-
-
33745151060
-
(2S,3S-3-Amino-4-(3,3-difluoropyrrolidin- 1-yl)-N, N-dimethyl-4-oxo-2-(4-[1 2,4]triazolo[1,5-A]-pyridin-6-ylphenyl)butanamide: A selective alpha-amino amide dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
-
Edmondson SD, Mastracchio A, Mathvink RJ et al (2006) (2S,3S)-3-Amino-4-(3,3-difluoropyrrolidin- 1-yl)-N, N-dimethyl-4-oxo-2-(4-[1,2,4]triazolo[1,5-a]-pyridin-6-ylphenyl)butanamide: a selective alpha-amino amide dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. J Med Chem 49: 3614-3627
-
(2006)
J Med Chem
, vol.49
, pp. 3614-3627
-
-
Edmondson, S.D.1
Mastracchio, A.2
Mathvink, R.J.3
-
92
-
-
41149089891
-
Fluoroolefins as amide bond mimics in dipeptidyl peptidase IV inhibitors
-
Edmondson SD, Wei L, Xu J et al (2008) Fluoroolefins as amide bond mimics in dipeptidyl peptidase IV inhibitors. Bioorg Med Chem Lett 18: 2409-2413
-
(2008)
Bioorg Med Chem Lett
, vol.18
, pp. 2409-2413
-
-
Edmondson, S.D.1
Wei, L.2
Xu, J.3
-
93
-
-
34249280590
-
Rational design of a novel, potent, and orally bioavailable cyclohexylamine DPP-4 inhibitor by application of molecular modeling and Xray crystallography of sitagliptin
-
Biftu T, Scapin G, Singh S et al (2007) Rational design of a novel, potent, and orally bioavailable cyclohexylamine DPP-4 inhibitor by application of molecular modeling and Xray crystallography of sitagliptin. Bioorg Med Chem Lett 17: 3384-3387
-
(2007)
Bioorg Med Chem Lett
, vol.17
, pp. 3384-3387
-
-
Biftu, T.1
Scapin, G.2
Singh, S.3
-
94
-
-
37349073397
-
8-(3-®-aminopiperidin-1-yl)-7-but-2-ynyl- 3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes
-
Eckhardt M, Langkopf E, Mark M et al (2007) 8-(3-®-aminopiperidin-1-yl)-7-but-2-ynyl- 3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes. J Med Chem 50: 6450-6453
-
(2007)
J Med Chem
, vol.50
, pp. 6450-6453
-
-
Eckhardt, M.1
Langkopf, E.2
Mark, M.3
-
95
-
-
34548812342
-
4-arylcyclohexylalanine analogs as potent, selective, and orally active inhibitors of dipeptidyl peptidase IV
-
Kaelin DE, Smenton AL, Eiermann GJ et al (2007) 4-arylcyclohexylalanine analogs as potent, selective, and orally active inhibitors of dipeptidyl peptidase IV. Bioorg Med Chem Lett 17: 5806-5811
-
(2007)
Bioorg Med Chem Lett
, vol.17
, pp. 5806-5811
-
-
Kaelin, D.E.1
Smenton, A.L.2
Eiermann, G.J.3
-
96
-
-
67649922154
-
Discovery of beta-homophenylalanine based pyrrolidin-2-ylmethyl amides and sulfonamides as highly potent and selective inhibitors of dipeptidyl peptidase IV
-
Nordhoff S, Cerezo-Gálvez S, Deppe H, Hill O, López-Canet M, Rummey C, Thiemann M, Matassa VG, Edwards PJ, Feurer A (2009) Discovery of beta-homophenylalanine based pyrrolidin-2-ylmethyl amides and sulfonamides as highly potent and selective inhibitors of dipeptidyl peptidase IV. Bioorg Med Chem Lett 19: 4201-4203
-
(2009)
Bioorg Med Chem Lett
, vol.19
, pp. 4201-4203
-
-
Nordhoff, S.1
Cerezo-Gálvez, S.2
Deppe, H.3
Hill, O.4
López-Canet, M.5
Rummey, C.6
Thiemann, M.7
Matassa, V.G.8
Edwards, P.J.9
Feurer, A.10
-
97
-
-
70350513554
-
Novel method for generating structure-based pharmacophores using energetic analysis
-
Salam NK, Nuti R, Sherman W (2009) Novel method for generating structure-based pharmacophores using energetic analysis. J Chem Inf Model 49: 2356-2368
-
(2009)
J Chem Inf Model
, vol.49
, pp. 2356-2368
-
-
Salam, N.K.1
Nuti, R.2
Sherman, W.3
-
98
-
-
67651002876
-
Energetic analysis of fragment docking and application to structure-based pharmacophore hypothesis generation
-
Loving K, Salam NK, Sherman W (2009) Energetic analysis of fragment docking and application to structure-based pharmacophore hypothesis generation. J Comput Aided Mol Des 23: 541-554
-
(2009)
J Comput Aided Mol des
, vol.23
, pp. 541-554
-
-
Loving, K.1
Salam, N.K.2
Sherman, W.3
-
99
-
-
84866312460
-
Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (part I): Virtual screening and activity assays
-
Guasch L, Ojeda MJ, González-Abuín N et al (2012) Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (part I): virtual screening and activity assays. PLoS One 7: e44971
-
(2012)
PLoS One
, vol.7
, pp. e44971
-
-
Guasch, L.1
Ojeda, M.J.2
González-Abuín, N.3
-
100
-
-
33845648469
-
Homology models of dipeptidyl peptidases 8 and 9 with a focus on loop predictions near the active site
-
Rummey C, Metz G (2007) Homology models of dipeptidyl peptidases 8 and 9 with a focus on loop predictions near the active site. Proteins 66: 160-171
-
(2007)
Proteins
, vol.66
, pp. 160-171
-
-
Rummey, C.1
Metz, G.2
-
101
-
-
84876703878
-
Homology modeling and molecular docking studies of human DPP8 and DPP9
-
Janardhan S, Reddy YP (2011) Homology modeling and molecular docking studies of human DPP8 and DPP9. Int J Pharma Res Dev 2: 131-146
-
(2011)
Int J Pharma Res Dev
, vol.2
, pp. 131-146
-
-
Janardhan, S.1
Reddy, Y.P.2
-
102
-
-
84934438577
-
Prediction of dipeptidyl peptidase (DP) 8 structure by homology modelling
-
Pitman MR, Menz RI, Abbott CA (2006) Prediction of dipeptidyl peptidase (DP) 8 structure by homology modelling. Adv Exp Med Biol 575: 33-42
-
(2006)
Adv Exp Med Biol
, vol.575
, pp. 33-42
-
-
Pitman, M.R.1
Menz, R.I.2
Abbott, C.A.3
-
103
-
-
84897122919
-
Novel hydrazine derivatives as selective DPP-IV inhibitors: Findings from virtual screening and validation through molecular dynamics simulations
-
Tanwar O, Deora GS, Tanwar L, Kumar G, Janardhan S, Alam MM, Shaquiquzzaman M, Akhter M (2014) Novel hydrazine derivatives as selective DPP-IV inhibitors: findings from virtual screening and validation through molecular dynamics simulations. J Mol Model 20: 2118
-
(2014)
J Mol Model
, vol.20
, pp. 2118
-
-
Tanwar, O.1
Deora, G.S.2
Tanwar, L.3
Kumar, G.4
Janardhan, S.5
Alam, M.M.6
Shaquiquzzaman, M.7
Akhter, M.8
-
104
-
-
34250206962
-
Docking-based 3D-QSAR study for selectivity of DPP4, DPP8, and DPP9 inhibitors
-
Kang NS, Ahn JH, Kim SS, Chae CH, Yoo S-E (2007) Docking-based 3D-QSAR study for selectivity of DPP4, DPP8, and DPP9 inhibitors. Bioorg Med Chem Lett 17: 3716-3721
-
(2007)
Bioorg Med Chem Lett
, vol.17
, pp. 3716-3721
-
-
Kang, N.S.1
Ahn, J.H.2
Kim, S.S.3
Chae, C.H.4
Yoo, S.-E.5
-
105
-
-
84894175214
-
Recent approaches to medicinal chemistry and therapeutic potential of dipeptidyl peptidase-4 (DPP-4) inhibitors
-
Patel BD, Ghate MD (2014) Recent approaches to medicinal chemistry and therapeutic potential of dipeptidyl peptidase-4 (DPP-4) inhibitors. Eur J Med Chem 74: 574-605
-
(2014)
Eur J Med Chem
, vol.74
, pp. 574-605
-
-
Patel, B.D.1
Ghate, M.D.2
-
106
-
-
84876741806
-
Structure based lead optimization approach in discovery of selective DPP4 inhibitors
-
Ghate M, Jain SV (2013) Structure based lead optimization approach in discovery of selective DPP4 inhibitors. Mini Rev Med Chem 13: 888-914
-
(2013)
Mini Rev Med Chem
, vol.13
, pp. 888-914
-
-
Ghate, M.1
Jain, S.V.2
-
107
-
-
84869093408
-
A novel, potent, and longlasting dipeptidyl peptidase-4 inhibitor, teneligliptin, improves postprandial hyperglycemia and dyslipidemia after single and repeated administrations
-
Fukuda-Tsuru S, Anabuki J, Abe Y, Yoshida K, Ishii S (2012) A novel, potent, and longlasting dipeptidyl peptidase-4 inhibitor, teneligliptin, improves postprandial hyperglycemia and dyslipidemia after single and repeated administrations. Eur J Pharmacol 696: 194-202
-
(2012)
Eur J Pharmacol
, vol.696
, pp. 194-202
-
-
Fukuda-Tsuru, S.1
Anabuki, J.2
Abe, Y.3
Yoshida, K.4
Ishii, S.5
-
108
-
-
84893792992
-
Fragment based HQSAR modeling and docking analysis of conformationally rigid 3-azabicyclo hexane derivatives to design selective DPP-4 inhibitors
-
Ghate M, Jain S (2014) Fragment based HQSAR modeling and docking analysis of conformationally rigid 3-azabicyclo hexane derivatives to design selective DPP-4 inhibitors. Lett Drug Des Discov 11: 184-198
-
(2014)
Lett Drug des Discov
, vol.11
, pp. 184-198
-
-
Ghate, M.1
Jain, S.2
-
109
-
-
84892649479
-
Standards of medical care in diabetes-2014
-
American Diabetes Association
-
American Diabetes Association (2014) Standards of medical care in diabetes-2014. Diabetes Care 37(Suppl 1): S14-S80
-
(2014)
Diabetes Care
, vol.37
, pp. S14-S80
-
-
-
110
-
-
38449089793
-
Virtual screening for the discovery of bioactive natural products
-
Rollinger JM, Stuppner H, Langer T (2008) Virtual screening for the discovery of bioactive natural products. Prog drug Res 65: 211, 213-249
-
(2008)
Prog Drug Res
, vol.65
, Issue.211
, pp. 213-249
-
-
Rollinger, J.M.1
Stuppner, H.2
Langer, T.3
-
111
-
-
78049522482
-
Identification of bioactive natural products by pharmacophore- based virtual screening
-
Schuster D, Wolber G (2010) Identification of bioactive natural products by pharmacophore- based virtual screening. Curr Pharm Des 16: 1666-1681
-
(2010)
Curr Pharm des
, vol.16
, pp. 1666-1681
-
-
Schuster, D.1
Wolber, G.2
-
113
-
-
60549091563
-
Nutrigenomics approaches to functional foods
-
Ferguson LLR (2009) Nutrigenomics approaches to functional foods. J Am Diet Assoc 109: 452-458
-
(2009)
J Am Diet Assoc
, vol.109
, pp. 452-458
-
-
Llr, F.1
-
114
-
-
33846130946
-
Screening of inhibitors of porcine dipeptidyl peptidase IV activity in aqueous extracts from marine organisms
-
Pascual I, Lopéz A, Gómez H, Chappé M, Saroyán A, González Y, Cisneros M, Charli JL, Chávez MDLA (2007) Screening of inhibitors of porcine dipeptidyl peptidase IV activity in aqueous extracts from marine organisms. Enzyme Microb Technol 40: 414-419
-
(2007)
Enzyme Microb Technol
, vol.40
, pp. 414-419
-
-
Pascual, I.1
Lopéz, A.2
Gómez, H.3
Chappé, M.4
Saroyán, A.5
González, Y.6
Cisneros, M.7
Charli, J.L.8
Mdla, C.9
-
115
-
-
74549184604
-
Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberine
-
Al-masri IM, Mohammad MK, Tahaa MO (2009) Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberine. J Enzyme Inhib Med Chem 24: 1061-1066
-
(2009)
J Enzyme Inhib Med Chem
, vol.24
, pp. 1061-1066
-
-
Al-Masri, I.M.1
Mohammad, M.K.2
Tahaa, M.O.3
-
116
-
-
84882581155
-
Experimental diabetes treated with trigonelline: Effect on key enzymes related to diabetes and hypertension, β -cell and liver function
-
Hamden K, Bengara A, Amri Z, Elfeki A (2013) Experimental diabetes treated with trigonelline: effect on key enzymes related to diabetes and hypertension, β-cell and liver function. Mol Cell Biochem 381: 85-94
-
(2013)
Mol Cell Biochem
, vol.381
, pp. 85-94
-
-
Hamden, K.1
Bengara, A.2
Amri, Z.3
Elfeki, A.4
-
117
-
-
84894081011
-
Evaluation of (arene)Ru(II) complexes of curcumin as inhibitors of dipeptidyl peptidase IV
-
Antonyan A, De A, Vitali L, Pettinari R, Marchetti F, Gigliobianco MR, Pettinari C, Camaioni E, Lupidi G (2014) Evaluation of (arene)Ru(II) complexes of curcumin as inhibitors of dipeptidyl peptidase IV. Biochimie 99: 146-152
-
(2014)
Biochimie
, vol.99
, pp. 146-152
-
-
Antonyan, A.1
De A Vitali, L.2
Pettinari, R.3
Marchetti, F.4
Gigliobianco, M.R.5
Pettinari, C.6
Camaioni, E.7
Lupidi, G.8
-
118
-
-
84866411751
-
Grape seed-derived procyanidins decrease dipeptidyl-peptidase 4 activity and expression
-
González-Abuín N, Martínez-Micaelo N, Blay M, Pujadas G, Garcia-Vallvé S, Pinent M, Ardévol A (2012) Grape seed-derived procyanidins decrease dipeptidyl-peptidase 4 activity and expression. J Agric Food Chem 60: 9055-9061
-
(2012)
J Agric Food Chem
, vol.60
, pp. 9055-9061
-
-
González-Abuín, N.1
Martínez-Micaelo, N.2
Blay, M.3
Pujadas, G.4
Garcia-Vallvé, S.5
Pinent, M.6
Ardévol, A.7
-
119
-
-
79959270961
-
Fast and effective identification of the bioactive compounds and their targets from medicinal plants via computational chemical biology approach
-
Zhang S, Lu W, Liu X, Diao Y, Bai F, Wang L, Shan L, Huang J, Li H, Zhang W (2011) Fast and effective identification of the bioactive compounds and their targets from medicinal plants via computational chemical biology approach. MedChemComm 2: 471
-
(2011)
MedChemComm
, vol.2
, pp. 471
-
-
Zhang, S.1
Lu, W.2
Liu, X.3
Diao, Y.4
Bai, F.5
Wang, L.6
Shan, L.7
Huang, J.8
Li, H.9
Zhang, W.10
-
120
-
-
84866678743
-
Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (part II): In silico prediction in anti-diabetic extracts
-
Guasch L, Sala E, Ojeda MJ, Valls C, Bladé C, Mulero M, Blay M, Ardévol A, Garcia-Vallvé S, Pujadas G (2012) Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (part II): in silico prediction in anti-diabetic extracts. PLoS One 7: e44972
-
(2012)
PLoS One
, vol.7
, pp. e44972
-
-
Guasch, L.1
Sala, E.2
Ojeda, M.J.3
Valls, C.4
Bladé, C.5
Mulero, M.6
Blay, M.7
Ardévol, A.8
Garcia-Vallvé, S.9
Pujadas, G.10
-
121
-
-
84884256994
-
Berry and citrus phenolic compounds inhibit dipeptidyl peptidase IV: Implications in diabetes management
-
Fan J, Johnson MH, Lila MA, Yousef G, de Mejia EG (2013) Berry and citrus phenolic compounds inhibit dipeptidyl peptidase IV: implications in diabetes management. Evid Based Complement Alternat Med 2013: 479505
-
(2013)
Evid Based Complement Alternat Med
, vol.2013
, pp. 479505
-
-
Fan, J.1
Johnson, M.H.2
Lila, M.A.3
Yousef, G.4
De Mejia, E.G.5
-
122
-
-
84864095846
-
DPP-IV inhibitory potential of naringin: An in silico, in vitro and in vivo study
-
Parmar HS, Jain P, Chauhan DS et al (2012) DPP-IV inhibitory potential of naringin: an in silico, in vitro and in vivo study. Diabetes Res Clin Pract 97: 105-111
-
(2012)
Diabetes Res Clin Pract
, vol.97
, pp. 105-111
-
-
Parmar, H.S.1
Jain, P.2
Chauhan, D.S.3
-
123
-
-
84872871661
-
Bioassay-guided isolation of DPP-4 inhibitory fractions from extracts of submerged cultured of Inonotus obliquus
-
Geng Y, Lu Z-M, Huang W, Xu H-Y, Shi J-S, Xu Z-H (2013) Bioassay-guided isolation of DPP-4 inhibitory fractions from extracts of submerged cultured of Inonotus obliquus. Molecules 18: 1150-1161
-
(2013)
Molecules
, vol.18
, pp. 1150-1161
-
-
Geng, Y.1
Lu, Z.-M.2
Huang, W.3
Xu, H.-Y.4
Shi, J.-S.5
Xu, Z.-H.6
-
124
-
-
84870415970
-
Antihyperglycemic activity with DPP-IV inhibition of alkaloids from seed extract of Castanospermum australe: Investigation by experimental validation and molecular docking
-
Bharti SK, Krishnan S, Kumar A, Rajak KK, Murari K, Bharti BK, Gupta AK (2012) Antihyperglycemic activity with DPP-IV inhibition of alkaloids from seed extract of Castanospermum australe: investigation by experimental validation and molecular docking. Phytomedicine 20: 24-31
-
(2012)
Phytomedicine
, vol.20
, pp. 24-31
-
-
Bharti, S.K.1
Krishnan, S.2
Kumar, A.3
Rajak, K.K.4
Murari, K.5
Bharti, B.K.6
Gupta, A.K.7
-
125
-
-
84879503276
-
Aqueous seed extract of Syzygium cumini inhibits the dipeptidyl peptidase IV and adenosine deaminase activities, but it does not change the CD26 expression in lymphocytes in vitro
-
Bellé LP, Bitencourt PER, Abdalla FH, Bona KS de, Peres A, Maders LDK, Moretto MB (2013) Aqueous seed extract of Syzygium cumini inhibits the dipeptidyl peptidase IV and adenosine deaminase activities, but it does not change the CD26 expression in lymphocytes in vitro. J Physiol Biochem 69: 119-124
-
(2013)
J Physiol Biochem
, vol.69
, pp. 119-124
-
-
Bellé, L.P.1
Per, B.2
Abdalla, F.H.3
Bona, K.S.D.E.4
Peres, A.5
Ldk, M.6
Moretto, M.B.7
-
126
-
-
84860318855
-
Evaluation of the potential of dietary proteins as precursors of dipeptidyl peptidase (DPP)-IV inhibitors by an in silico approach
-
Lacroix IME, Li-Chan ECY (2012) Evaluation of the potential of dietary proteins as precursors of dipeptidyl peptidase (DPP)-IV inhibitors by an in silico approach. J Funct Foods 4: 403-422
-
(2012)
J Funct Foods
, vol.4
, pp. 403-422
-
-
Ime, L.1
Ecy, L.2
-
127
-
-
84884510206
-
Susceptibility of milk protein-derived peptides to dipeptidyl peptidase IV (DPP-IV) hydrolysis
-
Nongonierma AB, Fitzgerald RJ (2014) Susceptibility of milk protein-derived peptides to dipeptidyl peptidase IV (DPP-IV) hydrolysis. Food Chem 145: 845-852
-
(2014)
Food Chem
, vol.145
, pp. 845-852
-
-
Nongonierma, A.B.1
Fitzgerald, R.J.2
-
128
-
-
0025976294
-
Are diprotin A (Ile-Pro-Ile) and diprotin B (Val-Pro-Leu) inhibitors or substrates of dipeptidyl peptidase IV?
-
Rahfeld J, Schierhorn M, Hartrodt B, Neubert K, Heins J (1991) Are diprotin A (Ile-Pro-Ile) and diprotin B (Val-Pro-Leu) inhibitors or substrates of dipeptidyl peptidase IV? Biochim Biophys Acta 1076: 314-316
-
(1991)
Biochim Biophys Acta
, vol.1076
, pp. 314-316
-
-
Rahfeld, J.1
Schierhorn, M.2
Hartrodt, B.3
Neubert, K.4
Heins, J.5
-
129
-
-
79952799368
-
Whey proteins as source of dipeptidyl dipeptidase IV (dipeptidyl peptidase-4) inhibitors
-
Tulipano G, Sibilia V, Caroli AM, Cocchi D (2011) Whey proteins as source of dipeptidyl dipeptidase IV (dipeptidyl peptidase-4) inhibitors. Peptides 32: 835-838
-
(2011)
Peptides
, vol.32
, pp. 835-838
-
-
Tulipano, G.1
Sibilia, V.2
Caroli, A.M.3
Cocchi, D.4
-
130
-
-
84871549211
-
Dipeptidyl peptidase IV inhibitory and antioxidative properties of milk protein-derived dipeptides and hydrolysates
-
Nongonierma AB, FitzGerald RJ (2013) Dipeptidyl peptidase IV inhibitory and antioxidative properties of milk protein-derived dipeptides and hydrolysates. Peptides 39: 157-163
-
(2013)
Peptides
, vol.39
, pp. 157-163
-
-
Nongonierma, A.B.1
Fitzgerald, R.J.2
-
131
-
-
84878313919
-
Dipeptidyl peptidase- IV inhibitory peptides generated by tryptic hydrolysis of a whey protein concentrate rich in β-lactoglobulin
-
Silveira ST, MartVnez-Maqueda D, Recio I, Hernαndez-Ledesma B (2013) Dipeptidyl peptidase- IV inhibitory peptides generated by tryptic hydrolysis of a whey protein concentrate rich in β-lactoglobulin. Food Chem 141: 1072-1077
-
(2013)
Food Chem
, vol.141
, pp. 1072-1077
-
-
Silveira, S.T.1
Martínez-Maqueda, D.2
Recio, I.3
Hernández-Ledesma, B.4
-
132
-
-
84860295841
-
Production of dipeptidyl peptidase IV inhibitory peptides from defatted rice bran
-
Hatanaka T, Inoue Y, Arima J, Kumagai Y, Usuki H, Kawakami K, Kimura M, Mukaihara T (2012) Production of dipeptidyl peptidase IV inhibitory peptides from defatted rice bran. Food Chem 134: 797-802
-
(2012)
Food Chem
, vol.134
, pp. 797-802
-
-
Hatanaka, T.1
Inoue, Y.2
Arima, J.3
Kumagai, Y.4
Usuki, H.5
Kawakami, K.6
Kimura, M.7
Mukaihara, T.8
-
133
-
-
84859788742
-
Dipeptidyl-peptidase IV inhibitory activity of peptides derived from tuna cooking juice hydrolysates
-
Huang S-L, Jao C-L, Ho K-P, Hsu K-C (2012) Dipeptidyl-peptidase IV inhibitory activity of peptides derived from tuna cooking juice hydrolysates. Peptides 35: 114-121
-
(2012)
Peptides
, vol.35
, pp. 114-121
-
-
Huang, S.-L.1
Jao, C.-L.2
Ho, K.-P.3
Hsu, K.-C.4
-
134
-
-
84887176534
-
Dipeptidyl peptidase IV inhibitory peptides generated in Spanish dry-cured ham
-
Gallego M, Aristoy M-C, Toldrá F (2013) Dipeptidyl peptidase IV inhibitory peptides generated in Spanish dry-cured ham. Meat Sci 96: 757-761
-
(2013)
Meat Sci
, vol.96
, pp. 757-761
-
-
Gallego, M.1
Aristoy, M.-C.2
Toldrá, F.3
-
135
-
-
84861332110
-
Dipeptidyl peptidase-IV inhibitory activity of dairy protein hydrolysates
-
Lacroix IME, Li-Chan ECY (2012) Dipeptidyl peptidase-IV inhibitory activity of dairy protein hydrolysates. Int Dairy J 25: 97-102
-
(2012)
Int Dairy J
, vol.25
, pp. 97-102
-
-
Ime, L.1
Ecy, L.2
-
136
-
-
84866883091
-
In vitro inhibition of dipeptidyl peptidase IV by peptides derived from the hydrolysis of amaranth ( Amaranthus hypochondriacus L.) proteins
-
Velarde-Salcedo AJ, Barrera-Pacheco A, Lara-González S, Montero-Morán GM, Díaz- Gois A, González de Mejia E, Barba de la Rosa AP (2013) In vitro inhibition of dipeptidyl peptidase IV by peptides derived from the hydrolysis of amaranth ( Amaranthus hypochondriacus L.) proteins. Food Chem 136: 758-764
-
(2013)
Food Chem
, vol.136
, pp. 758-764
-
-
Velarde-Salcedo, A.J.1
Barrera-Pacheco, A.2
Lara-González, S.3
Montero-Morán, G.M.4
Díaz-Gois, A.5
De Mejia González, E.6
De La Barba Rosa, A.P.7
-
137
-
-
84884602268
-
Inhibition of dipeptidyl peptidase IV and xanthine oxidase by amino acids and dipeptides
-
Nongonierma AB, Mooney C, Shields DC, Fitzgerald RJ (2013) Inhibition of dipeptidyl peptidase IV and xanthine oxidase by amino acids and dipeptides. Food Chem 141: 644-653
-
(2013)
Food Chem
, vol.141
, pp. 644-653
-
-
Nongonierma, A.B.1
Mooney, C.2
Shields, D.C.3
Fitzgerald, R.J.4
-
138
-
-
84856555742
-
Peptides derived from atlantic salmon skin gelatin as dipeptidyl-peptidase IV inhibitors
-
Li-Chan ECY, Hunag S-L, Jao C-L, Ho K-P, Hsu K-C (2012) Peptides derived from atlantic salmon skin gelatin as dipeptidyl-peptidase IV inhibitors. J Agric Food Chem 60: 973-978
-
(2012)
J Agric Food Chem
, vol.60
, pp. 973-978
-
-
Ecy, L.1
Hunag, S.-L.2
Jao, C.-L.3
Ho, K.-P.4
Hsu, K.-C.5
-
139
-
-
82655173852
-
Isolation and identification of casein-derived dipeptidyl-peptidase 4 (DPP-4)-inhibitory peptide LPQNIPPL from goudatype cheese and its effect on plasma glucose in rats
-
Uenishi H, Kabuki T, Seto Y, Serizawa A, Nakajima H (2012) Isolation and identification of casein-derived dipeptidyl-peptidase 4 (DPP-4)-inhibitory peptide LPQNIPPL from goudatype cheese and its effect on plasma glucose in rats. Int Dairy J 22: 24-30
-
(2012)
Int Dairy J
, vol.22
, pp. 24-30
-
-
Uenishi, H.1
Kabuki, T.2
Seto, Y.3
Serizawa, A.4
Nakajima, H.5
-
140
-
-
80052897910
-
Novel dipeptidyl peptidase-4-inhibiting peptide derived from β-lactoglobulin
-
Uchida M, Ohshiba Y, Mogami O (2011) Novel dipeptidyl peptidase-4-inhibiting peptide derived from β-lactoglobulin. J Pharmacol Sci 117: 63-66
-
(2011)
J Pharmacol Sci
, vol.117
, pp. 63-66
-
-
Uchida, M.1
Ohshiba, Y.2
Mogami, O.3
-
141
-
-
63649106115
-
Milk proteins as precursors of bioactive peptides
-
Dziuba M, Dziuba B, Iwaniak A (2009) Milk proteins as precursors of bioactive peptides. Acta Sci Pol Technol Aliment 8(1): 71-90 (http://www.food.actapol.net/volume8/issue1/abstract-7.html
-
(2009)
Acta Sci Pol Technol Aliment
, vol.8
, Issue.1
, pp. 71-90
-
-
Dziuba, M.1
Dziuba, B.2
Iwaniak, A.3
-
142
-
-
79952353155
-
Bovine meat proteins as potential precursors of biologically active peptides - A computational study based on the BIOPEP database
-
Minkiewicz P, Dziuba J, Michalska J (2011) Bovine meat proteins as potential precursors of biologically active peptides-a computational study based on the BIOPEP database. Food Sci Technol Int 17: 39-45
-
(2011)
Food Sci Technol Int
, vol.17
, pp. 39-45
-
-
Minkiewicz, P.1
Dziuba, J.2
Michalska, J.3
-
143
-
-
11844279046
-
Synthesis and biological activity of sulphostin analogues, novel dipeptidyl peptidase IV inhibitors
-
Abe M, Akiyama T, Umezawa Y, Yamamoto K, Nagai M, Yamazaki H, Ichikawa Y-I, Muraoka Y (2005) Synthesis and biological activity of sulphostin analogues, novel dipeptidyl peptidase IV inhibitors. Bioorg Med Chem 13: 785-797
-
(2005)
Bioorg Med Chem
, vol.13
, pp. 785-797
-
-
Abe, M.1
Akiyama, T.2
Umezawa, Y.3
Yamamoto, K.4
Nagai, M.5
Yamazaki, H.6
Ichikawa, Y.-I.7
Muraoka, Y.8
-
144
-
-
0034798552
-
Sulphostin, a potent inhibitor for dipeptidyl peptidase IV from Streptomyces sp. MK251-43F3
-
Akiyama T, Abe M, Harada S et al (2001) Sulphostin, a potent inhibitor for dipeptidyl peptidase IV from Streptomyces sp. MK251-43F3. J Antibiot (Tokyo) 54: 744-746
-
(2001)
J Antibiot (Tokyo)
, vol.54
, pp. 744-746
-
-
Akiyama, T.1
Abe, M.2
Harada, S.3
-
145
-
-
0021230368
-
Diprotins A and B, inhibitors of dipeptidyl aminopeptidase IV, produced by bacteria
-
Umezawa H, Aoyagi T, Ogawa K, Naganawa H, Hamada M, Takeuchi T (1984) Diprotins A and B, inhibitors of dipeptidyl aminopeptidase IV, produced by bacteria. J Antibiot (Tokyo) 37: 422-425
-
(1984)
J Antibiot (Tokyo)
, vol.37
, pp. 422-425
-
-
Umezawa, H.1
Aoyagi, T.2
Ogawa, K.3
Naganawa, H.4
Hamada, M.5
Takeuchi, T.6
-
146
-
-
84874871709
-
A unified conformational selection and induced fit approach to protein-peptide docking
-
Trellet M, Melquiond A, Bonvin A (2013) A unified conformational selection and induced fit approach to protein-peptide docking. PLoS One 8: e58769
-
(2013)
PLoS One
, vol.8
, pp. e58769
-
-
Trellet, M.1
Melquiond, A.2
Bonvin, A.3
-
148
-
-
0026858424
-
Catalytic properties of X-prolyl dipeptidyl aminopeptidase from Lactococcus lactis subsp. cremoris nTR
-
Yan TR, Ho SC, Hou CL (1992) Catalytic properties of X-prolyl dipeptidyl aminopeptidase from Lactococcus lactis subsp. cremoris nTR. Biosci Biotechnol Biochem 56: 704-707
-
(1992)
Biosci Biotechnol Biochem
, vol.56
, pp. 704-707
-
-
Yan, T.R.1
Ho, S.C.2
Hou, C.L.3
-
149
-
-
0038531163
-
Different modes of dipeptidyl peptidase IV (CD26) inhibition by oligopeptides derived from the N-terminus of HIV-1 Tat indicate at least two inhibitor binding sites
-
Lorey S, Stöckel-Maschek A, Faust J et al (2003) Different modes of dipeptidyl peptidase IV (CD26) inhibition by oligopeptides derived from the N-terminus of HIV-1 Tat indicate at least two inhibitor binding sites. Eur J Biochem 270: 2147-2156
-
(2003)
Eur J Biochem
, vol.270
, pp. 2147-2156
-
-
Lorey, S.1
Stöckel-Maschek, A.2
Faust, J.3
-
150
-
-
84875470601
-
Development of a natural products database from the biodiversity of Brazil
-
Valli M, dos Santos RN, Figueira LD, Nakajima CH, Castro-Gamboa I, Andricopulo AD, Bolzani VS (2013) Development of a natural products database from the biodiversity of Brazil. J Nat Prod 76: 439-444
-
(2013)
J Nat Prod
, vol.76
, pp. 439-444
-
-
Valli, M.1
Dos Santos, R.N.2
Figueira, L.D.3
Nakajima, C.H.4
Castro-Gamboa, I.5
Andricopulo, A.D.6
Bolzani, V.S.7
-
151
-
-
79251561193
-
TCM database@Taiwan: The world's largest traditional Chinese medicine database for drug screening in silico
-
Chen CY-C (2011) TCM database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico. PLoS One 6: e15939
-
(2011)
PLoS One
, vol.6
, pp. e15939
-
-
Cy-C, C.1
-
154
-
-
84864199587
-
ZINC: A free tool to discover chemistry for biology
-
Irwin JJ, Sterling T, Mysinger MM, Bolstad ES, Coleman RG (2012) ZINC: a free tool to discover chemistry for biology. J Chem Inf Model 52: 1757-1768
-
(2012)
J Chem Inf Model
, vol.52
, pp. 1757-1768
-
-
Irwin, J.J.1
Sterling, T.2
Mysinger, M.M.3
Bolstad, E.S.4
Coleman, R.G.5
-
155
-
-
84866656363
-
Pseudo ephedrine from Ephedra alata
-
Black OF, Kelly JW (1927) Pseudo ephedrine from Ephedra alata. Am J Pharm 99: 748-751
-
(1927)
Am J Pharm
, vol.99
, pp. 748-751
-
-
Black, O.F.1
Kelly, J.W.2
-
156
-
-
0025157737
-
Study into wild Egyptian plants of potential medicinal activity Ninth communication: Hypoglycaemic activity of some selected plants in normal fasting and alloxanised rats
-
Shabana MM, Mirhom YW, Genenah AA, Aboutabl EA, Amer HA (1990) Study into wild Egyptian plants of potential medicinal activity. Ninth communication: hypoglycaemic activity of some selected plants in normal fasting and alloxanised rats. Arch Exp Veterinarmed 44: 389-394
-
(1990)
Arch Exp Veterinarmed
, vol.44
, pp. 389-394
-
-
Shabana, M.M.1
Mirhom, Y.W.2
Genenah, A.A.3
Aboutabl, E.A.4
Amer, H.A.5
-
157
-
-
0022042322
-
Isolation and hypoglycemic activity of ephedrans A, B, C, D and E, glycans of Ephedra distachya herbs
-
Konno C, Mizuno T, Hikino H (1985) Isolation and hypoglycemic activity of ephedrans A, B, C, D and E, glycans of Ephedra distachya herbs. Planta Med 51: 162-163
-
(1985)
Planta Med
, vol.51
, pp. 162-163
-
-
Konno, C.1
Mizuno, T.2
Hikino, H.3
-
159
-
-
0016745577
-
Studies on the erythrina alkaloids. X. Alkaloids of several Erythrina plants from Singapore (author's transl)
-
Ito K, Haruna M, Furukawa H (1975) Studies on the erythrina alkaloids. X. Alkaloids of several Erythrina plants from Singapore (author's transl). Yakugaku Zasshi 95: 358-362
-
(1975)
Yakugaku Zasshi
, vol.95
, pp. 358-362
-
-
Ito, K.1
Haruna, M.2
Furukawa, H.3
-
160
-
-
79955810318
-
Hypoglycemic activity of Erythrina variegata leaf in streptozotocin-induced diabetic rats
-
Kumar A, Lingadurai S, Shrivastava TP, Bhattacharya S, Haldar PK (2011) Hypoglycemic activity of Erythrina variegata leaf in streptozotocin-induced diabetic rats. Pharm Biol 49: 577-582
-
(2011)
Pharm Biol
, vol.49
, pp. 577-582
-
-
Kumar, A.1
Lingadurai, S.2
Shrivastava, T.P.3
Bhattacharya, S.4
Haldar, P.K.5
-
161
-
-
59449102510
-
Diacylglycerol acyltransferase-inhibitory compounds from Erythrina senegalensis
-
Oh WK, Lee C-H, Seo JH, Chung MY, Cui L, Fomum ZT, Kang JS, Lee HS (2009) Diacylglycerol acyltransferase-inhibitory compounds from Erythrina senegalensis. Arch Pharm Res 32: 43-47
-
(2009)
Arch Pharm Res
, vol.32
, pp. 43-47
-
-
Oh, W.K.1
Lee, C.-H.2
Seo, J.H.3
Chung, M.Y.4
Cui, L.5
Fomum, Z.T.6
Kang, J.S.7
Lee, H.S.8
-
162
-
-
33845916144
-
Protein tyrosine phosphatase-1B inhibitory activity of isoprenylated flavonoids isolated from Erythrina mildbraedii
-
Na M, Jang J, Njamen D, Mbafor JT, Fomum ZT, Kim BY, Oh WK, Ahn JS (2006) Protein tyrosine phosphatase-1B inhibitory activity of isoprenylated flavonoids isolated from Erythrina mildbraedii. J Nat Prod 69: 1572-1576
-
(2006)
J Nat Prod
, vol.69
, pp. 1572-1576
-
-
Na, M.1
Jang, J.2
Njamen, D.3
Mbafor, J.T.4
Fomum, Z.T.5
Kim, B.Y.6
Oh, W.K.7
Ahn, J.S.8
-
163
-
-
33748592544
-
Inhibition of protein tyrosine phosphatase 1B by prenylated isoflavonoids isolated from the stem bark of Erythrina addisoniae
-
Bae EY, Na M, Njamen D, Mbafor JT, Fomum ZT, Cui L, Choung DH, Kim BY, Oh WK, Ahn JS (2006) Inhibition of protein tyrosine phosphatase 1B by prenylated isoflavonoids isolated from the stem bark of Erythrina addisoniae. Planta Med 72: 945-948
-
(2006)
Planta Med
, vol.72
, pp. 945-948
-
-
Bae, E.Y.1
Na, M.2
Njamen, D.3
Mbafor, J.T.4
Fomum, Z.T.5
Cui, L.6
Choung, D.H.7
Kim, B.Y.8
Oh, W.K.9
Ahn, J.S.10
-
164
-
-
0001302093
-
Isolation and characterization of two guanidines from Galega orientalis Lam. Cv. Gale (fodder galega)
-
Benn MH, Shustov G, Shustova L, Majak W, Bai Y, Fairey NA (1996) Isolation and characterization of two guanidines from Galega orientalis Lam. Cv. Gale (fodder galega). J Agric Food Chem 44: 2779-2781
-
(1996)
J Agric Food Chem
, vol.44
, pp. 2779-2781
-
-
Benn, M.H.1
Shustov, G.2
Shustova, L.3
Majak, W.4
Bai, Y.5
Fairey, N.A.6
-
165
-
-
21644470416
-
Herbal remedies in the management of diabetes: Lessons learned from the study of ginseng
-
Vuksan V, Sievenpiper JL (2005) Herbal remedies in the management of diabetes: lessons learned from the study of ginseng. Nutr Metab Cardiovasc Dis 15: 149-160
-
(2005)
Nutr Metab Cardiovasc Dis
, vol.15
, pp. 149-160
-
-
Vuksan, V.1
Sievenpiper, J.L.2
-
167
-
-
85027474820
-
Verlauf der Alkaloidbildung durch den Clavicepsstamm von Pennisetum typhoideum Rich. in saprophytischer Kultur. Mitteilung über Mutterkornalkaloide
-
Brack A (1962) Verlauf der Alkaloidbildung durch den Clavicepsstamm von Pennisetum typhoideum Rich. in saprophytischer Kultur. Mitteilung über Mutterkornalkaloide. Arch Pharm (Weinheim) 295: 510-515
-
(1962)
Arch Pharm (Weinheim)
, vol.295
, pp. 510-515
-
-
Brack, A.1
-
168
-
-
0026236325
-
Glycaemic response to maize, bajra and barley
-
Shukla K, Narain JP, Puri P, Gupta A, Bijlani RL, Mahapatra SC, Karmarkar MG (1991) Glycaemic response to maize, bajra and barley. Indian J Physiol Pharmacol 35: 249-254
-
(1991)
Indian J Physiol Pharmacol
, vol.35
, pp. 249-254
-
-
Shukla, K.1
Narain, J.P.2
Puri, P.3
Gupta, A.4
Bijlani, R.L.5
Mahapatra, S.C.6
Karmarkar, M.G.7
-
169
-
-
0036321335
-
New alkaloids of the sarpagine group from Rauvolfia serpentina hairy root culture
-
Sheludko Y, Gerasimenko I, Kolshorn H, Stöckigt J (2002) New alkaloids of the sarpagine group from Rauvolfia serpentina hairy root culture. J Nat Prod 65: 1006-1010
-
(2002)
J Nat Prod
, vol.65
, pp. 1006-1010
-
-
Sheludko, Y.1
Gerasimenko, I.2
Kolshorn, H.3
Stöckigt, J.4
-
170
-
-
0021358781
-
Cerebral and cerebellar metabolic changes induced by drugs during the recovery period after profound hypoglycemia
-
Benzi G, Villa RF, Dossena M, Vercesi L, Gorini A, Pastoris O (1984) Cerebral and cerebellar metabolic changes induced by drugs during the recovery period after profound hypoglycemia. Farmaco Sci 39: 44-56
-
(1984)
Farmaco Sci
, vol.39
, pp. 44-56
-
-
Benzi, G.1
Villa, R.F.2
Dossena, M.3
Vercesi, L.4
Gorini, A.5
Pastoris, O.6
-
172
-
-
33644846963
-
Tissue lipid lowering-effect of a traditional Nigerian anti-diabetic infusion of Rauwolfia vomitoria foilage and Citrus aurantium fruit
-
Campbell JIA, Mortensen A, Mølgaard P (2006) Tissue lipid lowering-effect of a traditional Nigerian anti-diabetic infusion of Rauwolfia vomitoria foilage and Citrus aurantium fruit. J Ethnopharmacol 104: 379-386
-
(2006)
J Ethnopharmacol
, vol.104
, pp. 379-386
-
-
Jia, C.1
Mortensen, A.2
Mølgaard, P.3
-
173
-
-
33645540082
-
Chemical and biological evaluation on scopadulane-type diterpenoids from Scoparia dulcis of Vietnamese origin
-
Phan MG, Phan TS, Matsunami K, Otsuka H (2006) Chemical and biological evaluation on scopadulane-type diterpenoids from Scoparia dulcis of Vietnamese origin. Chem Pharm Bull (Tokyo) 54: 546-549
-
(2006)
Chem Pharm Bull (Tokyo)
, vol.54
, pp. 546-549
-
-
Phan, M.G.1
Phan, T.S.2
Matsunami, K.3
Otsuka, H.4
-
174
-
-
7744223453
-
Scoparia dulcis, a traditional anti-diabetic plant, protects against streptozotocin induced oxidative stress and apoptosis in vitro and in vivo
-
Latha M, Pari L, Sitasawad S, Bhonde R (2004) Scoparia dulcis, a traditional anti-diabetic plant, protects against streptozotocin induced oxidative stress and apoptosis in vitro and in vivo. J Biochem Mol Toxicol 18: 261-272
-
(2004)
J Biochem Mol Toxicol
, vol.18
, pp. 261-272
-
-
Latha, M.1
Pari, L.2
Sitasawad, S.3
Bhonde, R.4
-
175
-
-
79951710339
-
Improving epinephrine responses in hypoglycemia unawareness with real-time continuous glucose monitoring in adolescents with type 1 diabetes
-
Ly TT, Hewitt J, Davey RJ, Lim EM, Davis EA, Jones TW (2011) Improving epinephrine responses in hypoglycemia unawareness with real-time continuous glucose monitoring in adolescents with type 1 diabetes. Diabetes Care 34: 50-52
-
(2011)
Diabetes Care
, vol.34
, pp. 50-52
-
-
Ly, T.T.1
Hewitt, J.2
Davey, R.J.3
Lim, E.M.4
Davis, E.A.5
Jones, T.W.6
-
176
-
-
79952363044
-
1-((3S,4S)-4-amino-1-(4-substituted- 1,3,5-triazin-2-yl) pyrrolidin-3-yl)-5,5-difluoropiperidin-2-one inhibitors of DPP-4 for the treatment of type 2 diabetes
-
Andrews KM, Beebe D A, Benbow JW et al (2011) 1-((3S,4S)-4-amino-1-(4-substituted- 1,3,5-triazin-2-yl) pyrrolidin-3-yl)-5,5-difluoropiperidin-2-one inhibitors of DPP-4 for the treatment of type 2 diabetes. Bioorg Med Chem Lett 21: 1810-1814
-
(2011)
Bioorg Med Chem Lett
, vol.21
, pp. 1810-1814
-
-
Andrews, K.M.1
Beebe, D.A.2
Benbow, J.W.3
-
177
-
-
67449123051
-
Anti-diabetic activities of Tecoma stans (L.) Juss. ex Kunth
-
Aguilar-Santamaría L, Ramírez G, Nicasio P, Alegría-Reyes C, Herrera-Arellano A (2009) Anti-diabetic activities of Tecoma stans (L.) Juss. ex Kunth. J Ethnopharmacol 124: 284-288
-
(2009)
J Ethnopharmacol
, vol.124
, pp. 284-288
-
-
Aguilar-Santamaría, L.1
Ramírez, G.2
Nicasio, P.3
Alegría-Reyes, C.4
Herrera-Arellano, A.5
-
178
-
-
0001747533
-
Hypoglycaemic properties of tecomine and tecostanine
-
Hammouda Y, Rashid A-K, Amer MS (1964) Hypoglycaemic properties of tecomine and tecostanine. J Pharm Pharmacol 16: 833-834
-
(1964)
J Pharm Pharmacol
, vol.16
, pp. 833-834
-
-
Hammouda, Y.1
Rashid, A.-K.2
Amer, M.S.3
-
179
-
-
49149112327
-
Anti-diabetic screening and scoring of 11 plants traditionally used in South Africa
-
Van de Venter M, Roux S, Bungu LC et al (2008) Anti-diabetic screening and scoring of 11 plants traditionally used in South Africa. J Ethnopharmacol 119: 81-86
-
(2008)
J Ethnopharmacol
, vol.119
, pp. 81-86
-
-
Van De Venter, M.1
Roux, S.2
Bungu, L.C.3
-
180
-
-
0034779111
-
New flavanol derivatives from grape ( Vitis vinifera) byproducts. Antioxidant aminoethylthio-flavan-3-ol conjugates from a polymeric waste fraction used as a source of flavanols
-
Torres JL, Bobet R (2001) New flavanol derivatives from grape ( Vitis vinifera) byproducts. Antioxidant aminoethylthio-flavan-3-ol conjugates from a polymeric waste fraction used as a source of flavanols. J Agric Food Chem 49: 4627-4634
-
(2001)
J Agric Food Chem
, vol.49
, pp. 4627-4634
-
-
Torres, J.L.1
Bobet, R.2
-
181
-
-
9244249143
-
Grape seed-derived procyanidins have an antihyperglycemic effect in streptozotocin-induced diabetic rats and insulinomimetic activity in insulin-sensitive cell lines
-
Pinent M, Blay M, Bladé MC, Salvadó MJ, Arola L, Ardévol A (2004) Grape seed-derived procyanidins have an antihyperglycemic effect in streptozotocin-induced diabetic rats and insulinomimetic activity in insulin-sensitive cell lines. Endocrinology 145: 4985-4990
-
(2004)
Endocrinology
, vol.145
, pp. 4985-4990
-
-
Pinent, M.1
Blay, M.2
Bladé, M.C.3
Salvadó, M.J.4
Arola, L.5
Ardévol, A.6
-
182
-
-
2142752964
-
Epigallocatechin gallate prevents autoimmune diabetes induced by multiple low doses of streptozotocin in mice
-
Song E-K, Hur H, Han M-K (2003) Epigallocatechin gallate prevents autoimmune diabetes induced by multiple low doses of streptozotocin in mice. Arch Pharm Res 26: 559-563
-
(2003)
Arch Pharm Res
, vol.26
, pp. 559-563
-
-
Song, E.-K.1
Hur, H.2
Han, M.-K.3
-
183
-
-
84877922064
-
Structure of two new diterpene alkaloids, 3-epi-ignavinol and 2,3-dehydrodelcosine
-
Takayama H, Okazaki T, Yamaguchi K, Aimi N, Haginiwa J et al (1988) Structure of two new diterpene alkaloids, 3-epi-ignavinol and 2,3-dehydrodelcosine. Chem Pharm Bull (Tokyo) 36(8): 3210-3212
-
(1988)
Chem Pharm Bull (Tokyo
, vol.36
, Issue.8
, pp. 3210-3212
-
-
Takayama, H.1
Okazaki, T.2
Yamaguchi, K.3
Aimi, N.4
Haginiwa, J.5
-
184
-
-
0022041207
-
Isolation and hypoglycemic activity of aconitans A, B, C and D, glycans of Aconitum carmichaeli roots
-
Konno C, Murayama M, Sugiyama K, Arai M, Murakami M, Takahashi M, Hikino H (1985) Isolation and hypoglycemic activity of aconitans A, B, C and D, glycans of Aconitum carmichaeli roots. Planta Med 51: 160-161
-
(1985)
Planta Med
, vol.51
, pp. 160-161
-
-
Konno, C.1
Murayama, M.2
Sugiyama, K.3
Arai, M.4
Murakami, M.5
Takahashi, M.6
Hikino, H.7
-
185
-
-
84870943005
-
Plants used in the treatment of diabetes
-
Soumyanath A (ed). CRC, Boca Raton
-
Howes M, Simmonds M (2005) Plants used in the treatment of diabetes. In: Soumyanath A (ed) Traditional medicines for modern times. CRC, Boca Raton.
-
(2005)
Traditional Medicines for Modern Times
-
-
Howes, M.1
Simmonds, M.2
-
186
-
-
33847040326
-
Indole alkaloids from three species of the Ervatamia genus: E. officinalis, E. divaricata, and E. divaricata Gouyahua
-
Zhang H, Wang X-N, Lin L-P, Ding J, Yue J-M (2007) Indole alkaloids from three species of the Ervatamia genus: E. officinalis, E. divaricata, and E. divaricata Gouyahua. J Nat Prod 70: 54-59
-
(2007)
J Nat Prod
, vol.70
, pp. 54-59
-
-
Zhang, H.1
Wang, X.-N.2
Lin, L.-P.3
Ding, J.4
Yue, J.-M.5
-
187
-
-
71749096644
-
Anti-diabetic effect of orally administered conophylline- containing plant extract on streptozotocin-treated and Goto-Kakizaki rats
-
Fujii M, Takei I, Umezawa K (2009) Anti-diabetic effect of orally administered conophylline- containing plant extract on streptozotocin-treated and Goto-Kakizaki rats. Biomed Pharmacother 63: 710-716
-
(2009)
Biomed Pharmacother
, vol.63
, pp. 710-716
-
-
Fujii, M.1
Takei, I.2
Umezawa, K.3
-
188
-
-
0000639354
-
Solanudine, a steroidal alkaloid from Solanum nudum
-
Usubillaga A (1988) Solanudine, a steroidal alkaloid from Solanum nudum. Phytochemistry 27: 3031-3032
-
(1988)
Phytochemistry
, vol.27
, pp. 3031-3032
-
-
Usubillaga, A.1
-
189
-
-
33947402587
-
Structures of steroidal alkaloid oligoglycosides, robeneosides A and B, and antidiabetogenic constituents from the Brazilian medicinal plant Solanum lycocarpum
-
Yoshikawa M, Nakamura S, Ozaki K, Kumahara A, Morikawa T, Matsuda H (2007) Structures of steroidal alkaloid oligoglycosides, robeneosides A and B, and antidiabetogenic constituents from the Brazilian medicinal plant Solanum lycocarpum. J Nat Prod 70: 210-214
-
(2007)
J Nat Prod
, vol.70
, pp. 210-214
-
-
Yoshikawa, M.1
Nakamura, S.2
Ozaki, K.3
Kumahara, A.4
Morikawa, T.5
Matsuda, H.6
-
190
-
-
32544447408
-
Comparative anti-hyperglycemic potentials of medicinal plants
-
Villaseñor IM, Lamadrid MRA (2006) Comparative anti-hyperglycemic potentials of medicinal plants. J Ethnopharmacol 104: 129-131
-
(2006)
J Ethnopharmacol
, vol.104
, pp. 129-131
-
-
Villaseñor, I.M.1
Mra, L.2
-
192
-
-
33751055994
-
Studies on hypoglycaemic activity of Solanum xanthocarpum Schrad. & Wendl. fruit extract in rats
-
Kar DM, Maharana L, Pattnaik S, Dash GK (2006) Studies on hypoglycaemic activity of Solanum xanthocarpum Schrad. & Wendl. fruit extract in rats. J Ethnopharmacol 108: 251-256
-
(2006)
J Ethnopharmacol
, vol.108
, pp. 251-256
-
-
Kar, D.M.1
Maharana, L.2
Pattnaik, S.3
Dash, G.K.4
-
193
-
-
0030897789
-
Alkaloidal constituents of the leaves of Stephania cepharantha cultivated in Japan: Structure of cephasugine, a new morphinane alkaloid
-
Kashiwaba N, Morooka S, Ono M, Toda J, Suzuki H et al (1997) Alkaloidal constituents of the leaves of Stephania cepharantha cultivated in Japan: structure of cephasugine, a new morphinane alkaloid. Chem Pharm Bull (Tokyo) 45(3): 545-548
-
(1997)
Chem Pharm Bull (Tokyo)
, vol.45
, Issue.3
, pp. 545-548
-
-
Kashiwaba, N.1
Morooka, S.2
Ono, M.3
Toda, J.4
Suzuki, H.5
-
194
-
-
0028715619
-
Hypoglycemic effects of three plants from eastern himalayan belt
-
Mosihuzzaman M, Nahar N, Ali L, Rokeya B, Khan AK et al (1994) Hypoglycemic effects of three plants from eastern himalayan belt. Diabetes Res 26(3): 127-138
-
(1994)
Diabetes Res
, vol.26
, Issue.3
, pp. 127-138
-
-
Mosihuzzaman, M.1
Nahar, N.2
Ali, L.3
Rokeya, B.4
Khan, A.K.5
-
195
-
-
77949597508
-
Anti-hyperglycemic effect of 11-hydroxypalmatine, a palmatine derivative from Stephania glabra tubers
-
Semwal DK, Rawat U, Semwal R, Singh R, Singh GJP (2010) Anti-hyperglycemic effect of 11-hydroxypalmatine, a palmatine derivative from Stephania glabra tubers. J Asian Nat Prod Res 12: 99-105
-
(2010)
J Asian Nat Prod Res
, vol.12
, pp. 99-105
-
-
Semwal, D.K.1
Rawat, U.2
Semwal, R.3
Singh, R.4
Singh, G.J.P.5
-
196
-
-
0037703416
-
Anti-hyperglycemic effect of fangchinoline Isolated from Stephania tetrandra radix in streptozotocin-diabetic mice
-
Tsutsumi T, Kobayashi S, Liu YY, Kontani H (2003) Anti-hyperglycemic effect of fangchinoline Isolated from Stephania tetrandra radix in streptozotocin-diabetic mice. Biol Pharm Bull 26: 313-317
-
(2003)
Biol Pharm Bull
, vol.26
, pp. 313-317
-
-
Tsutsumi, T.1
Kobayashi, S.2
Liu, Y.Y.3
Kontani, H.4
-
197
-
-
0001138596
-
Alkaloids of Tabernaemontana eglandulosa
-
Beek TAV, Verpoorte R, Svendsen AB (1984) Alkaloids of Tabernaemontana eglandulosa. Tetrahedron 40(4): 737
-
(1984)
Tetrahedron
, vol.40
, Issue.4
, pp. 737
-
-
Tav, B.1
Verpoorte, R.2
Svendsen, A.B.3
-
198
-
-
84873686290
-
Drug repositioning by structure-based virtual screening
-
Ma D-L, Chan DS-H, Leung C-H (2013) Drug repositioning by structure-based virtual screening. Chem Soc Rev 42: 2130-2141
-
(2013)
Chem Soc Rev
, vol.42
, pp. 2130-2141
-
-
Ma, D.-L.1
Ds-H, C.2
Leung, C.-H.3
-
199
-
-
84884576643
-
Computational profiling of bioactive compounds using a target-dependent composite workflow
-
doi: 10.1021/ci400303n
-
Meslamani J, Bhajun R, Martz F, Rognan D (2013) Computational profiling of bioactive compounds using a target-dependent composite workflow. J Chem Inf Model 53: 2322-2333 doi: 10.1021/ci400303n
-
(2013)
J Chem Inf Model
, vol.53
, pp. 2322-2333
-
-
Meslamani, J.1
Bhajun, R.2
Martz, F.3
Rognan, D.4
-
200
-
-
84875745014
-
Identifying multiple-target ligands via computational chemogenomics approaches
-
Peng S, Lin X, Guo Z, Huang N (2012) Identifying multiple-target ligands via computational chemogenomics approaches. Curr Top Med Chem 12: 1363-1375
-
(2012)
Curr Top Med Chem
, vol.12
, pp. 1363-1375
-
-
Peng, S.1
Lin, X.2
Guo, Z.3
Huang, N.4
-
201
-
-
84905679808
-
Computational approaches to drug repurposing and pharmacolog- session introduction
-
Swamidass SJ, Lu Z, Agarwal P, Butte AJ (2014) Computational approaches to drug repurposing and pharmacolog- session introduction. Pac Symp Biocomput 19: 110-113
-
(2014)
Pac Symp Biocomput
, vol.19
, pp. 110-113
-
-
Swamidass, S.J.1
Lu, Z.2
Agarwal, P.3
Butte, A.J.4
-
202
-
-
84889262928
-
Polypharmacology-foe or friend?
-
Peters J-U (2013) Polypharmacology-foe or friend? J Med Chem 56: 8955-8971
-
(2013)
J Med Chem
, vol.56
, pp. 8955-8971
-
-
Peters, J.-U.1
-
203
-
-
84865453273
-
Virtual target screening: Validation using kinase inhibitors
-
Santiago DN, Pevzner Y, Durand AA, Tran M, Scheerer RR, Daniel K, Sung S-S, Woodcock HL, Guida WC, Brooks WH (2012) Virtual target screening: validation using kinase inhibitors. J Chem Inf Model 52: 2192-2203
-
(2012)
J Chem Inf Model
, vol.52
, pp. 2192-2203
-
-
Santiago, D.N.1
Pevzner, Y.2
Durand, A.A.3
Tran, M.4
Scheerer, R.R.5
Daniel, K.6
Sung, S.-S.7
Woodcock, H.L.8
Guida, W.C.9
Brooks, W.H.10
-
204
-
-
84865249165
-
Approaches to target profiling of natural products
-
Yue R, Shan L, Yang X, Zhang W (2012) Approaches to target profiling of natural products. Curr Med Chem 19: 3841-3855
-
(2012)
Curr Med Chem
, vol.19
, pp. 3841-3855
-
-
Yue, R.1
Shan, L.2
Yang, X.3
Zhang, W.4
-
205
-
-
40549130652
-
PDTD: A web-accessible protein database for drug target identification
-
Gao Z, Li H, Zhang H, Liu X, Kang L, Luo X, Zhu W, Chen K, Wang X, Jiang H (2008) PDTD: a web-accessible protein database for drug target identification. BMC Bioinformatics 9: 104
-
(2008)
BMC Bioinformatics
, vol.9
, pp. 104
-
-
Gao, Z.1
Li, H.2
Zhang, H.3
Liu, X.4
Kang, L.5
Luo, X.6
Zhu, W.7
Chen, K.8
Wang, X.9
Jiang, H.10
-
206
-
-
33747829590
-
TarFisDock: A web server for identifying drug targets with docking approach
-
Li H, Gao Z, Kang L et al (2006) TarFisDock: a web server for identifying drug targets with docking approach. Nucleic Acids Res 34: W219-W224
-
(2006)
Nucleic Acids Res
, vol.34
, pp. W219-W224
-
-
Li, H.1
Gao, Z.2
Kang, L.3
-
207
-
-
80054911951
-
LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery
-
Laskowski RA, Swindells MB (2011) LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model 51: 2778-2786
-
(2011)
J Chem Inf Model
, vol.51
, pp. 2778-2786
-
-
Laskowski, R.A.1
Swindells, M.B.2
|